Entry Point Capital, LLC Lantheus Holdings, Inc. Call Options Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LNTH
# of Institutions
524Shares Held
67.4MCall Options Held
1.19MPut Options Held
837K-
Black Rock Inc. New York, NY8.6MShares$752 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.57MShares$662 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$292 Million0.15% of portfolio
-
State Street Corp Boston, MA2.49MShares$218 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.28MShares$199 Million0.89% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $6.01B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...